Complex Regional Pain Syndrome (CRPS) — Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2021 To 2032
Complex regional pain syndrome (CRPS), also known as Sudecks dystrophy or reflex sympathetic dystrophy, is a painful disease characterised by pain, sensory, Sudo- and vasomotor disturbances, trophic changes, and impaired motor function. CRPS patients are treated by physicians from various clinical backgrounds, including anaesthesiologists, (orthopaedic) surgeons, neurologists, rheumatologists, and rehabilitation centres, due to the complexity and broad spectrum of symptoms.
- The prevalence of CRPS varied between 7.68 to 27.1 cases per 100,000 population in 2020.
Thelansis’s “Complex Regional Pain Syndrome (CRPS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2021 To 2032” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Complex Regional Pain Syndrome (CRPS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Complex Regional Pain Syndrome (CRPS) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Complex Regional Pain Syndrome (CRPS) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
